Updated:
Genoa Ventures
Genoa Ventures invests where biology and technology converge. It identifies these opportunities early and focuses its investments and expertise to empower...
Genoa Ventures
Genoa Ventures invests where biology and technology converge. It identifies these opportunities early and focuses its investments and expertise to empower category-defying companies to create a healthier, cleaner, more productive world. Its founding principle is to help increase the performance and stability of portfolio companies on their journey to full potential. The team brings diverse experience from investing, operating, researching, discovering, and launching and scaling across biology and technology.
General information
Firm type
Venture Capital
Year founded
2018
Location
Region
North America
Country
United States
City
San Francisco
Corporate office
San Francisco, CA, United States
Principals
Jenny Rooke
Landon Merrill
Partner
Sector focus
Frequently asked questions
What investment thesis does Genoa Ventures pursue?
Genoa Ventures invests under a 'Biology by Design' thesis, targeting platform companies at the intersection of biology and computation, synthetic biology, lab automation, and AI-driven drug discovery. The firm treats biology as an engineering discipline and seeks companies whose core intellectual property is a proprietary dataset and a computational loop that improves biological outputs over time. This distinguishes Genoa from life sciences investors focused on single-asset therapeutic plays.
Which sectors is Genoa Ventures known to invest in?
The firm's primary sector concentrations are AI/ML-driven life sciences, lab automation, synthetic biology, computational drug discovery, and digital health platforms. Investment priorities favor companies where software and data science are as central to the value proposition as the underlying biological science.
Where is Genoa Ventures headquartered and where does it invest geographically?
Genoa Ventures is headquartered in San Francisco, California. The firm invests across North America and Europe, with a particular concentration in life sciences and computational biology talent hubs — principally the Bay Area, Boston, and London.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: